Yu Haichuan, Lei Ting, Su Xiaojie, Zhang Lu, Feng Zhouzhou, Chen Xinlong, Liu Jian
Intensive Care Unit, Lanzhou University First Affiliated Hospital, Lanzhou, China.
Clinical Medicine Department, First Clinical Medical Academy, Lanzhou University, Lanzhou, China.
Front Pharmacol. 2023 Jan 20;14:1024807. doi: 10.3389/fphar.2023.1024807. eCollection 2023.
No consensus exists on the antibiotic treatment course for patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD). Former studies indicate that shorter courses might have the same efficacy with fewer adverse events, which is inconsistent with guidelines and general practice. Existing evidence allows us to conduct a systematic review and Bayesian analysis on this topic. Four databases were searched from their inception to January 5, 2023. All statistical estimations were performed using R. "" was the core package of analysis. CINeMA was used to assess the grade of confidence of the results. Fourteen studies were included in the Bayesian meta-analysis. No difference in the clinical success rate of antibiotic treatment was observed from a super short course (1-3 days) to a long course (≥10 days). Considering the adverse events, the short course (4-6 days) might be the safest. The majority of results were of high or moderate confidence grade. Short course might cause the fewest adverse events. The clinical efficacy of antibiotics might not depend on the course length. Undeniably, more systematic explorations are warranted to investigate the clinical application of a shorter course of antibiotic treatment.
对于慢性阻塞性肺疾病急性加重期(AECOPD)患者的抗生素治疗疗程,目前尚无共识。既往研究表明,较短疗程可能具有相同疗效且不良事件较少,这与指南和一般临床实践不一致。现有证据使我们能够对该主题进行系统评价和贝叶斯分析。检索了四个数据库,检索时间从各数据库创建至2023年1月5日。所有统计估计均使用R进行。“”是分析的核心软件包。使用CINeMA评估结果的置信度等级。十四项研究纳入了贝叶斯荟萃分析。从超短疗程(1 - 3天)到长疗程(≥10天),未观察到抗生素治疗临床成功率的差异。考虑到不良事件,短疗程(4 - 6天)可能是最安全的。大多数结果的置信度等级为高或中等。短疗程可能导致最少的不良事件。抗生素的临床疗效可能不取决于疗程长短。不可否认,需要进行更多系统的探索来研究较短疗程抗生素治疗的临床应用。